Search references for NIVASOREXANT. Phrases containing NIVASOREXANT
See searches and references containing NIVASOREXANT!NIVASOREXANT
Chemical compound
Nivasorexant (INNTooltip International Nonproprietary Name; developmental code name ACT-539313) is an orexin receptor antagonist which is under development
Nivasorexant
Class of drugs
approved for insomnia in Japan in August 2025 – half-life 1.5–3 hours Nivasorexant (ACT-539313) – selective OX1 antagonist – under development for binge
Orexin_antagonist
Novel chemistry compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Alixorexton
Medication
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Oveporexton
G-protein-coupled receptor
receptor antagonist JNJ-10397049 – selective OX2 receptor antagonist Nivasorexant (ACT-539313) – selective OX1 receptor antagonist Rocavorexant (C4X-3256;
Orexin_receptor
Insomnia medication
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Lemborexant
Medication used to treat insomnia
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Daridorexant
Medication used to treat insomnia
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Suvorexant
Neuropeptide that regulates arousal, wakefulness, and appetite
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Orexin
Orexin antagonist compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Almorexant
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Firazorexton
Experimental anti-insomnia drug
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Seltorexant
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Danavorexton
Pharmaceutical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Cleminorexton
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Filorexant
Stimulating neuropeptide
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Orexin-A
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Tebideutorexant
Investigational anxiety disorder drugs
GABAA receptor positive allosteric modulator and benzodiazepine [108] Nivasorexant (ACT-539313; SORA) – orexin OX1 receptor antagonist [109] NS-11821 (NS11821)
List of investigational anxiety disorder drugs
List_of_investigational_anxiety_disorder_drugs
Pharmaceutical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Balumorexton
Pharmaceutical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Ledasorexton
Orexin receptor antagonist
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Fazamorexant
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Suntinorexton
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
SB-649868
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Vornorexant
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
SB-408124
Investigational eating disorder drugs
spray; OPNT-001) – μ-opioid receptor antagonist – eating disorders [5] Nivasorexant (ACT-539313; SORA) – orexin OX1 receptor antagonist – binge-eating disorder
List of investigational eating disorder drugs
List_of_investigational_eating_disorder_drugs
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
EMPA_(drug)
Protein-coding gene in the species Homo sapiens
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Orexin_receptor_type_2
Pharmaceutical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Rocavorexant
Orexin antagonist
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
TCS-OX2-29
Protein found in humans
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
Hypocretin (orexin) receptor 1
Hypocretin_(orexin)_receptor_1
Orexin antagonist
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
RTIOX-276
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
SB-334867
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
ACT-335827
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
JNJ-10397049
Chemical compound
Fazamorexant (YZJ-1139) Filorexant GSK-649868 (SB-649868) Lemborexant Nivasorexant (ACT-539313) Rocavorexant (C4X-3256; INDV-2000 RTIOX-276 SB-334867 SB-408124
ACT-462206
travel, tourism, insurance
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
NIVASOREXANT
travel, tourism, insurance